Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Revenue

Shanghai Shen Lian Biomedical had revenue of 62.60M CNY in the quarter ending March 31, 2026, a decrease of -20.50%. This brings the company's revenue in the last twelve months to 272.12M, down -7.47% year-over-year. In the year 2025, Shanghai Shen Lian Biomedical had annual revenue of 288.27M, down -4.99%.

• Revenue (ttm): 272.12M
• Revenue Growth: -7.47%
• P/S Ratio: 13.29
• Revenue / Employee: 695.97K
• Employees: 374
• Market Cap: 3.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	288.27M	-15.15M	-4.99%
Dec 31, 2024	303.41M	1.93M	0.64%
Dec 31, 2023	301.49M	-27.11M	-8.25%
Dec 31, 2022	328.59M	-29.83M	-8.32%
Dec 31, 2021	358.43M	20.70M	6.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error